Postradical prostatectomy erectile dysfunction (pRP-ED) is a major health issue. There has been a shortage of an effective treatment method until now. In this study, a total of 48 adult male Sprague-Dawley (SD) rats were randomly equally divided into four groups, including group 1-sham surgery with cavernous nerve exposure plus vehicle, group 2-bilateral cavernous nerve injury (BCNI) plus vehicle, group 3-BCNI plus adipose-derived mesenchymal stem cells (ADSCs)-derived exosomes (ADSC-Exo), and group 4-BCNI plus bone marrow-derived mesenchymal stem cell (BMSCs)-derived exosomes (BMSC-Exo). Twenty-one days following surgery, erectile function was measured before tissue harvest. Histologic and Western blot analyses were then performed. Exosomes were capable of internalization into human umbilical vein endothelial cells (HUVEC) in vitro and could be detected in the corpus cavernosum in vivo. The nNOS expression in the penile dorsal nerves (DN) and major pelvic ganglion (MPG), protein level of neurofilament in the DN, endothelial markers vWF, alpha smooth muscle actin (a-SMA), the ratio of smooth muscle to collagen content were obviously lower in BCNI group compared with the sham group, while ADSC-Exo and BMSC-Exo groups resulted in significant restoration of the above histopathological changes. Moreover, BCNI treated with ADSC-Exo or BMSC-Exo had significantly higher mean intracavernous pressure/mean arterial pressure ratio compared with BCNI group. The results demonstrated that both ADSC-Exo and BMSC-Exo treatment could significantly alleviate pathological changes and improve the erectile function in BCNIrelated rats. Exosomes derived from ADSCs and BMSCs may be a potential agent for pRP-ED treatment.
INTRODUCTION
Prostate cancer (PCa) is one of the most common cancers in males. There is growing incidence year by year all over the world. Radical prostatectomy (RP) acts as the dominant standard treatment method for PCa, but it always results in a number of complications, including erectile dysfunction, stress urinary incontinence, rectal injury, and so forth. Among these, postprostatectomy erectile dysfunction (pRP-ED) can be viewed as a multifactorial disorder, the interlinked mechanisms of which include denervation, endothelial dysfunction, and structural alterations in connective tissue and smooth muscle cells. The rate of pRP-ED ranges from 14% to 90%, mainly depending on the surgical approach and on the surgical experience, and may substantially influence quality of life (Saleh et al., 2015) . Although phosphodiesterase 5 inhibitors (PDE5Is) are widely used as first-line medication for treating ED at present, their impact on organic ED are less and also show symptoms of side-effects (Yiou, 2017) . Therefore, it is necessary to find a comparatively safe and effective method of improving the erectile function after RP.
Mesenchymal stem cells therapy has been reported to effectively improve the erectile dysfunction and ameliorate the pathological changes such as endothelial cells, smooth muscle, cavernous nerve, all those of which were damaged to varying degrees in the process of ED in several animal models (Mangir & Turkeri, 2017) . It is postulated that the underlying mechanisms for tissue regeneration mainly comprise transdifferentiation and soluble factors secreted by stem cells. With experience, and with improved apparatus, it is now possible to make a speculation that a preponderance of paracrine, when compared with transdifferentiation, is the important role in the process of disease occurrence and development. For instance, Yiou et al. (2016) found that delivery of human mesenchymal adipose-derived stem cells restores erectile dysfunction in a rat model mimicking radical prostatectomy and the regenerative effects were not due to the transdifferentiation and robust engraftment at injection sites, but due to a paracrine process by producing not only soluble factors released by the stem cells but also activation of the recipient's secretome of regenerating tissues. It is well known that two of the key components of the paracrine by stem cells are soluble functional proteins and exosomes, but the detailed inner working mechanism among them is still a mystery. Exosomes, a size around 30-120 nm microvesicles derived from various stem cells, had been applied widely in experimental animal research and also have been showed to bear the similar beneficial treatment effects with the stem cells. Exosomes are enriched with mRNAs, DNA, microRNAs, and proteins, which can be transported into the recipient cells leading to the regulation of cell migration, angiogenesis, invasiveness, immune response, and metastasis in the physiological and pathological processes of numerous diseases (Yu et al., 2014; Motavaf et al., 2016) .
Previous data in our laboratory have demonstrated that both adipose-derived mesenchymal stem cells (ADSCs) and ADSCsbased micro-tissues ameliorated the erectile dysfunction in a bilateral cavernous nerves injury (BCNI) model (Xu et al., 2014) . Additionally, further investigation found that the therapeutic effects might be related to the upregulation of some paracrine factors by stem cells to some extent, but the real mechanism is still unclear. Considering exosomes are one of the most important stem cells paracrine composition, and there is no evidence for exosomes treatment in a rat model of bilateral cavernous nerves injury, we first applied the exosomes from ADSCs and bone marrow-derived mesenchymal stem cells (BMSCs) to treat the bilateral cavernous nerves of crushed rats to investigate their potential therapeutic effects.
MATERIALS AND METHODS

Experimental design
A total of 48 12-week-old Sprague-Dawley male rats were obtained from Animal Breeding Center at Peking University Health Science Center. The experiments were approved by the institutional animal care and use subcommittee of our university. Twelve rats were randomly selected as sham control group (midline abdominal incision with no cavernous nerve crush). The other 36 rats were subjected to development of erectile dysfunction by bilateral cavernous nerve crush as previously described procedure . Three days later, the 36 rats were randomly equally divided into three groups and received an intracavernous (IC) injection of phosphate-buffered saline (PBS) (BCNI group), 100 lg proteins of exosomes derived from ADSCs (ADSC-Exo group) and 100 lg proteins of exosomes derived from BMSCs (BMSC-Exo group). The sham group received an IC injection of PBS. Twenty-one days after injection, the rats in each group were examined for erectile function before tissue harvest.
Exosomes isolation and identification
Primary ADSCs and BMSCs were purchased from ScienCell Research Laboratories and cultured using mesenchymal stem cell medium (MSCM, Cat. #7501). Cells at passage three were cultured in medium including 5% exosomes-depleted FBS (Exo-FBS, System Biosciences, Mountain View, CA, USA) to avoid any contamination of shed membrane fragments and vesicles from serum. The ADSC-Exo isolation and BMSC-Exo isolation were performed using the PureExo Exosome isolation kit (101Bio, Mountain View, CA, USA) according to the manufacturer's protocol. Exosomes were stored at À20°C before use. The protein concentrations of exosomes were determined by Bicinchoninic Protein Assay (BCA method) using the manufacturer's protocol (Thermo Scientific TM Pierce TM BCA TM Protein Assay). The isolated exosomes were prepared by the Exosome-TEM-easy kit (101Bio) and then characterized morphologically by TEM observation. Furthermore, the exosomes markers expression of HSP70, CD81, and CD63 was analyzed by Western blotting.
CN injury and IC injection of exosomes
The rats were first weighed and anesthetized with 5% pentobarbital sodium (45 mg/kg), the major pelvic ganglion (MPG) and CN could be found on both sides of the prostate. The nerve crush site was 2-5 mm distal to the MPG, and bilateral CN crush injury was performed as previously described . The sham surgery was performed in exactly the same way without nerves crushed. For IC injections, rats were anesthetized and placed in the supine position. The prepuce was rolled up to expose the penis, then exosomes (100 lg of protein) were injected into the lateral aspect of the penis. The needle was inserted by 3-4 mm and stay 3 min after the injection. Artery clamps (JD-S-101, JEUNG DO BIO & Plant CO, LTD, Seoul, Korea) were used to block the blood circulation for holding the ADSC-Exo and BMSC-Exo in corpus cavernosum (CC) situ lasting 30 min after IC of exosomes.
CM-Dil-labeled exosomes
Exosomes derived from ADSCs and BMSCs first reacted with CM-Dil dye (CM-Dil; Molecular Probes) according to the manufacture's protocol. Then, the labeled exosomes suspension was filtered with a 100 kDa MWCO hollow fiber membrane (Microcon YM-100, Millipore, Darmstadt, Germany) and resuspended in PBS for 3 times to remove excess dye.
Tracking the exosomes in vitro and vivo
CM-Dil-Labeled exosomes were co-cultured with human umbilical vein endothelial cells (HUVEC) in exosome-depleted FBS medium overnight at 37°C. Following fixed with 4% paraformaldehyde and stained with 4 0 , 6-diamidino-2-phenylindole (DAPI, Invitrogen, Carlsbad, CA, USA), the cells were observed under a fluorescence microscope. 24 h after IC, rats were euthanized and penile tissues were harvested to determine the distribution of CM-Dil-Labeled exosomes.
Evaluation of erectile function
The rats from each group were anesthetized with 5% pentobarbital sodium (45 mg/kg). The MPG, CN, and the penis were exposed. One 25-gauge needle connected to PE tube with heparin (250 U/mL) was inserted into the CC to measure intracavernous pressure (ICP); one 24-gauge indwelling needle connected to PE tube with heparin was inserted into the left carotid artery to measure mean arterial pressure (MAP). The other end of the two PE tubes was connected to Biopac Systems MP150 multichannel physiological signal recorder (Goleta, CA, 928 Andrology, 2018, 6, 927-935 USA). The stimulus parameters were 5V, 12 Hz, pulse width of 1 ms, and duration of 60 sec. The maximum increase in ICP for three stimuli per side for each animal was selected for statistical analysis of mean ICP. The ratio of maximal ICP to MAP was calculated to normalize for variations in systemic blood pressure.
Histologic analysis
After erectile function testing, the penis (midshaft portion), MPG, and distal CN were harvested. The tissues were paraffin embedded or optimum cutting temperature compound embedded. Paraffin sections were stained following the standard procedures for IHC. Penile tissue sections (5 lm) were deparaffinized and hydrated by sequential incubations in xylene and ethanol. After washing in phosphate-buffered saline (PBS) for 5 min, the sections were blocked with 3% H2O2 for 10 min to quench endogenous peroxidase activity and with heat-induced epitope retrieval methods to perform the antigen unmasking (antigen retrieval solution: 0.01 M sodium citrate buffer, pH 6.0). The tissue sections were incubated with antibody to anti-a-smooth muscle actin (aSMA, 1:1000; Abcam, Cambridge, MA, USA), rabbit anti-neuronal nitric oxide synthase (nNOS, 1:500, Abcam), followed by the use of the MaxVision HRP-Polymer immunohistochemistry kit (Maxim, China) and were developed in color with diaminobenzidine (DAB). Sections were then counterstained with hematoxylin.
Penile cryosections were stained for IF. Primary antibodies were rabbit anti-von willebrand factor (vWF, 1:500, Abcam), mouse anti-neurofilament medium (NF, 1:500, Abcam) and rabbit anti-neuronal nitric oxide synthase (nNOS, 1:200, Abcam). Secondary antibodies including Alexa-488 and Alexa-594-conjugated antibodies (1:500; Invitrogen) were then used for 1.5 h at room temperature. Smooth muscle was stained with AlexaFluor-488 conjugated phalloidin (1:100, Molecular Probes, Invitrogen Corporation, Grand Island, NY, USA). Nuclei were stained with 4 0 , 6-diamidino-2-phenylindole (Invitrogen) in the following. Masson trichrome staining was used to quantify the ratio between smooth muscle and collagen within the corpus cavernosum according to Masson's Trichrome staining protocol. Slides were then photographed and recorded using a LEICA DFC 425 C digital microscope camera system (Leica).
Western blot
Protein samples from penile tissues and exosomes were prepared by homogenization in RIPA lysis buffer. Primary antibodies to aSMA 
Image analysis and quantification
Images of tissue sections were captured with a digital camera (Leica DM2500, Leica Microsystems, Nussloch, Germany) and imported into IMAGE-PRO PLUS software (version 6.0, Media Cybernetics Inc, Bethesda, MD, USA) for calculating the mean density and dot numbers of each sample. The Western blot images were analyzed with IMAGEJ software (version 1.46r, Image J, NIH, Bethesda, MD, USA) to determine the integrated density value of each protein band.
Statistical analysis
The results are expressed as means AE SD. One-way ANOVA analysis followed by the Student-Newman-Keuls test was used to evaluate whether differences among groups were significant. All calculations were performed using SPSS statistical software (version 13.0, SPSS, Chicago, IL, USA). Probability values of <0.05 were considered significant.
RESULTS
Characterization of ADSCs and BMSCs-derived exosomes
By transmission electron microscope, the diameters of ADSCExo or BMSC-Exo were ranged from about 30 to 100 nm (Fig. 1A) . Both the exosomes showed the positive expression of exosomes markers, such as CD63, HSP70, and CD81, by Western blot (Fig. 1B) .
Tracking of the CM-Dil-labeled exosomes in vitro and vivo
We investigated whether ADSC-Exo or BMSC-Exo could enter into HUVEC as some studies have reported that exosomes could enter into cells and regulate their biological behavior. In our experiment, the labeled BMSC-Exo were incubated with HUVEC for 12 h, and the cellular uptake of BMSC-Exo was evaluated via fluorescence microscopy. In addition, the exosomes mainly localized to the perinuclear region, indicating that ADSC-Exo or BMSC-Exo can be internalized by HUVEC in vitro (Fig. 1C) . Furthermore, injection of CM-Dil-labeled BMSC-Exo into CC was also detected the positive staining at 24 h (Fig. 1D) . ADSC-Exo also had the similar results with those of the BMSC-Exo (data not shown).
Exosomes treatment improves erectile function after BCNI
Erectile function was assessed at day 21 post-surgery in all groups (Fig. 3) . The sham group exhibited normal ICP curves and high ICP/MAP ratio, whereas BCNI group consistently resulted in ED. The ICP/MAP ratio was lower for the BCNI group (0.48 AE 0.09) than for the sham group (0.83 AE 0.08). The effects of exosomes treatment on amelioration of erectile function were observed in the ADSC-Exo and BMSC-Exo group as reflected by significantly higher ICP/MAP ratios in response to cavernous nerve electrical stimulus (ADSC-Exo 0.62 AE 0.07; BMSC-Exo, 0.63 AE 0.06) (Fig. 2) .
IC-injected exosomes enhance nNOS-positive nerve regeneration
BCNI induced a significant decrease in nNOS-positive nerves in penile dorsal nerves (DN) and MPG. Significant amelioration of the nNOS expression in DN was observed both in the ADSCExo and BMSC-Exo groups. Rat MPGs were also examined for nNOS expression. The exosomes treatment groups showed an obvious improvement in MPG (Fig. 3) .
Improvement in nerve content in exosomes treated rats' dorsal nerve bundle
Double staining of nNOS and neurofilament demonstrated that lower expression of them was found in the BCNI group, while ADSC-Exo and BMSC-Exo treatment groups could effectively reverse the changes (Fig. 4) .
Exosomes promote endothelial cells regeneration
To determine the changes of endothelial cells, we evaluated the endothelial marker vWF expression in cavernous tissue by immunofluorescence (IF) . Results showed that the expression of vWF was significantly higher in the ADSC-Exo and BMSC-Exo groups than the BCNI group (Fig. 5) .
Pathological changes in the CC
BCNI caused CC smooth muscle atrophy. We performed immunohistochemical staining and Western blot to assess the smooth muscle content (Fig. 6) . The penile tissue from BCNI group showed significantly lower a-SMA-positive staining compared to sham group. Both exosomes derived from ADSCs and BMSCs exhibited partial but significant restoration of smooth muscle content after BCNI according to Western blot analysis. Importantly, exosomes reduced penile fibrosis after BCNI. In the sham group, the ratio of smooth muscle/collagen was 0.088 AE 0.008, which was evaluated qualitatively and semiquantitatively by Masson's trichrome staining. The ratio of the ADSC-Exo group (0.065 AE 0.004) and BMSC-Exo group (0.069 AE 0.005) was significantly higher than that in the BCNI group (0.039 AE 0.006) (Fig. 7) .
DISCUSSION
Prostate cancer is the most common cancer in males. The treatment of it is mainly resting on surgical radical prostatectomy and a number of complications will ensue. ED caused by RP first led to the neuropraxia, followed by reductions in smooth muscle content and increased fibrosis in penile tissue (Fode et al., 2013) . Previous animal studies (Xu et al., 2015) have demonstrated that CN injury was associated with ED and some pathophysiological consequences, including loss of smooth muscle, collagen deposition, decrease in nNOS-positive nerves, and Wallerian degeneration. Various stem cells, such as adipose tissue-derived stem cells, bone marrow-derived mesenchymal stem cells, musclederived stem cells, urine-derived stem cells, have been proved to effectively improve the cavernous nerve (CN) injuryinduced erectile dysfunction (Woo et al., 2011; Jeon et al., 2016; Martinez-Salamanca et al., 2016; Yang et al., 2016 Accordingly, many scientists put greater emphasis on the role of paracringing by stem cells. Proteomic analysis (Anderson et al., 2016) and small RNAsequencing analysis (Baglio et al., 2015) have proved that MSC-derived exosomes contain abundant functional proteins and microRNAs, which were transferred into recipient cells and played a critical role in mediating the multiple physiological and pathological functions, including proliferation and differentiation, immunomodulation and tumorigenesis. Moreover, stem cells-derived exosomes have been widely reported to play an important role in various diseases including cardiovascular disease, kidney injury, immune disease, tumor growth diseases (Burrello et al., 2016; Lin et al., 2016; Qi et al., 2017; Radosinska & Bartekova, 2017) . Recently, injection of exosomes for treating ED in a type 2 diabetic ED rat model and in STZ-diabetic rat model has been reported, respectively. Chen et al., (2017) found that ADSC-derived exosomes were capable of rescuing corpus cavernosum endothelial and smooth muscle cells by inhibiting apoptosis and thus promoting the recovery of erectile function in type 2 diabetic rats; Zhu et al., (2018) demonstrated ADSC-derived exosomes had the ability to promote angiogenesis and proliferating endothelial cells in vitro and restored erectile function in vivo, which was preliminarily explained by proangiogenic microRNAs (miR-126, miR-130a and miR-132) detected in the ADSC-derived exosomes.
There is no evidence that exosomes therapy is used for treating ED in BCNI rat model based on published articles at present. For this reason, the therapeutic effects of ADSCsand BMSCs-derived exosomes on erectile function improvement were explored. Purification, identification, and confirmation of bioactivity of exosomes derived from Human ADSCs and BMSCs were carried out; the timing of exosomes injection was carried out three days after BCNI, for the reason that erectile function can be severely damaged, and pathological damage is also formed three days after BCNI. From the results, lower expression of nNOS in DN and MPG, decreased NF, endothelial vWF, a-SMA expression and the ratio of smooth muscle to collagen content were found in the BCNI group, whereas after ADSC-Exo or BMSC-Exo treatment, they could both effectively restore the pathological sites and thus improve the erectile function to some degree. The beneficial effects for ADSC-Exo or BMSC-Exo treatment in BCNI rat model may be related with the exosomes as information vehicles by transferring microRNAs, mRNAs, and proteins into the recipient cells and promoting cell restoration through cell-cell communication. In this study, although we have observed the effect of exosomes on the amelioration of erectile dysfunction with injection of ADSC-Exo and MSCExo injection, some limitations still exist actually. Only a single dose of intracavernous injection was used in this study, which may only reflect exosomes' true benefit to a certain degree. So it is very necessary to optimize the treatment procure, varying according to the dosing, the number of treatments and the treating course. Further investigation is needed to figure out which types of microRNAs or proteins are involved in the repair process of the disease. All these will help us clearly explain the mechanism of restoring the erectile dysfunction by exosomes and thus bring a promising method for treating ED.
CONCLUSIONS
Both ADSC-Exo and BMSC-Exo could alleviate pathological changes including the distortion of normal neural anatomy, endothelial content, smooth muscle atrophy, collagen deposition and thus improve the erectile dysfunction in BCNI-related ED rats. ADSC-Exo or BMSC-Exo may be as a potential agent for pRP-ED treatment.
